ID | Age (years) | Gender | Syndrome | Medication |
---|---|---|---|---|
Non-PPR1 | 16 | M | JME | None |
Non-PPR2 | 28 | F | JME | Valproate |
Non-PPR3 | 30 | M | JME | Valproate |
Non-PPR4 | 19 | M | JME | None |
Non-PPR5 | 24 | F | JME | Levetiracetam |
Non-PPR6 | 18 | M | JME | Epilim |
Non-PPR7 | 19 | M | JME | None |
Non-PPR8 | 27 | F | JME | Valproate |
Non-PPR9 | 20 | F | JME | Lamotrigine |
Non-PPR10 | 18 | M | JME | None |
Non-PPR11 | 18 | F | JME | None |
Non-PPR12 | 22 | F | JME | Duloxetine |
Non-PPR13 | 22 | F | JME | Lamotrigine, carbamazepine |
Non-PPR14 | 23 | M | JME | None |
Non-PPR15 | 21 | F | JME | Topiramate, levetiracetam, clobazam |
Non-PPR16 | 30 | M | GTCSO | Carbamazepine |
Non-PPR17 | 20 | F | JME | Epilim |
Non-PPR18 | 20 | F | JME | None |
Non-PPR19 | 20 | M | JME | Valproate |
Non-PPR20 | 31 | F | JME | Lamotrigine, Sumatriptan |
M, Male; F, female; GTCSO, generalized tonic-clonic seizures only.